Global prevalence of eligibility for biologic therapy in ATS/ERS-defined severe asthma: A systematic review. [PDF]
World Allergy Organ JYang F +4 more
europepmc +1 more source
Optimizing Biologic Treatment Selection in Chronic Rhinosinusitis with Nasal Polyps: A Network Meta-Analysis of Efficacy and Safety Across 22 RCTs. [PDF]
Pharmaceuticals (Basel)Safia A +4 more
europepmc +1 more source
Exacerbation control in chronic obstructive pulmonary disease with tezepelumab: insights from the COURSE trial. [PDF]
J Thorac DisAfrose D, Valizadeh M, Sivapalan P.
europepmc +1 more source
Established and Emerging Biological Therapies for the Treatment of Comorbid Asthma and Chronic Obstructive Pulmonary Disease. [PDF]
J Inflamm ResCazzola M +3 more
europepmc +1 more source
Biologic Therapies in Severe Asthma and Eosinophilic Granulomatosis with Polyangiitis: Targeted Therapy and Personalized Care. [PDF]
Tuberc Respir Dis (Seoul)Kim SH.
europepmc +1 more source
The COURSE trial and beyond: rethinking chronic obstructive pulmonary disease exacerbation management with biologics. [PDF]
J Thorac DisKashizaki F, Chen H.
europepmc +1 more source
Clinical and Biological Remission With Tezepelumab: The Real-World Response in Severe Uncontrolled Asthma. [PDF]
AllergyGates J +12 more
europepmc +1 more source
Alpine Altitude Climate Treatment Improves Asthma Control, Irrespective of Biologics Use [PDF]
Drijver‐Messelink, Marieke T +5 more
core +1 more source
A Bispecific Antibody Blocking Both TSLP and IL-4Rα for the Treatment of Allergic Inflammatory Diseases. [PDF]
CellsYu M +7 more
europepmc +1 more source
Successful Desensitization to Tezepelumab in a Polysorbate-Allergic Patient
Journal of Investigational Allergy and Clinical ImmunologyS, Bautista-Villanueva +3 more
openaire +2 more sources